Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor (Q48788587)

15 February 2018

title

Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor (English)

1 reference

15 February 2018

author name string

Rosenzweig P

1

1 reference

15 February 2018

Patat A

2

1 reference

15 February 2018

Zieleniuk I

3

1 reference

15 February 2018

Cimarosti I

4

1 reference

15 February 2018

Allain H

5

1 reference

15 February 2018

Gandon JM

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

15 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

15 February 2018

volume

64

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

211-222

1 reference

15 February 2018

Memory Functions in Depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Pressor Effect of Oral Tyramine During Treatment with Befloxatone, a New Reversible Monoamine Oxidase‐A Inhibitor, in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Psychomotor function and psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Effects of antidepressants on skilled performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Use of memory tests in differentiating organic disorder from depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Non-MAOI antidepressant drugs and cognitive functions: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Cognitive performance in geriatric subjects after acute treatment with antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Behavioural toxicity of antidepressants with particular reference to moclobemide

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Pharmacoelectroencephalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

A continuous performance test of brain damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

The use of analogue scales in rating subjective feelings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

Psychological deficit in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

Effects of antidepressants on human performance: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

The effects of moclobemide on psychomotor performance and cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

Correlations between Serum Ami- and Nortriptyline Concentrations and Psychomotor Performance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990155-2

7 January 2021

10.1016/S0009-9236(98)90155-2

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018